Improving Clinical Trial Patient Diversity: Can Central Imaging Play a Role?
Centralized medical imaging providers must challenge their current processes to improve patient diversity.
Rare Disease Patients Overlooked During COVID
Survey data shows individuals are not informed on how COVID-19 could affect their conditions.
5 Ways DCTs Can Positively Impact Trial Diversity
COVID-19 forces life sciences industry to make long overdue changes.
The Many Paths of Diversity in Clinical Trials
How COVID-19 blazed a new trail for greater patient inclusion.
Contemplating the Full Measure of Pandemic Response
Affirming and advancing patient engagement and digital transformation.
Shifting from Paper to Digital Patient Consent
Charles Sydnor, CCRA, ACRP-CP, project manager at Crofoot, discusses how offering a digital patient experience in trials enables the site to provide better patient care.
The Tangled Web of Large Outsourced Providers
A brief look at the market for mergers and acquisitions since the year of COVID.
Clinical Trials Diversity and Inclusion
Chairman and Founder of MJH Life Sciences, Mike Hennessy Sr. explores the main discussion points covered in the June issue of ACT.
Applied Clinical Trials June 2021 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials June 2021 issue in an interactive PDF format.
Is COVID A Game-Changer for Wider Drug Development Policy?
Conclusions from the Global Health Summit provide plenty of support for research, innovation, investment, and incentivization.
FDA Promotes Master Protocols to Modernize Clinical Trials
FDA has responded to pressures for quick and reliable processes with multiple guidance documents and policy initiatives for updating the clinical research process.
Steps Toward Diversity in Clinical Trials: Building Authentic Trust
Building authentic trust lays at the heart of creating more patient-centric trials.
